Aridis Pharma gains as drug cocktail neutralizes Delta COVID-19 variant

Aridis Pharmaceuticals

12/07/2021 22:25

** Biopharmaceutical company's shares  ARDS.O  up as much as
9.37% at $7.88 after market
    ** ARDS says its dual antibody cocktail drug against
COVID-19 neutralizes the Delta variant of the virus  urn:newsml:reuters.com:*:nPnc7vRbRa
    ** Co says binding analyses project that the cocktail will
be effective against all variants on the U.S. Centers for
Disease Control's Variants of Interest and Variants of Concern
lists
    ** The drug will be delivered as an inhaled treatment -
ARDS  
    ** Co says it remains on track to finalize the Phase 1,2,3
design for the program and initiate the clinical study in H2
    ** Stock up ~20% YTD, as of last close

 (Reporting by Rithika Krishna in Bengaluru)
 ((Rithika.Krishna@thomsonreuters.com))